A T-cell-based enzyme-linked immunospot assay for tuberculosis screening in Chinese patients with rheumatic diseases receiving infliximab therapy

Clinical and Experimental Medicine

Volumn 11, Issue 3, 2011, Pages 155-161

  Xie, Xi ^a   Chen, Jin Wei ^a   Li, Fen ^a   Tian, Jing ^a   Gao, Jie Sheng ^a   Zhang, David ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b University of Washington   (United States)

Author keywords

Anti TNF therapy; Infliximab; T SPOT.TB; Tuberculosis

Indexed keywords

BCG VACCINE; CULTURE FILTRATE PROTEIN 10; CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; GLUCOCORTICOID; INFLIXIMAB; ISONIAZID; PREDNISONE; TUBERCULIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; BCG VACCINATION; BIOLOGICAL THERAPY; CELL STIMULATION; CHINA; CHINESE; CLINICAL EXAMINATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; INTERSTITIAL LUNG DISEASE; KAPPA STATISTICS; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MCNEMAR TEST; PATIENT MONITORING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REACTIVE ARTHRITIS; RELIABILITY; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SCREENING; SKIN INDURATION; SPONDYLOARTHROPATHY; T LYMPHOCYTE; T LYMPHOCYTE BASED ENZYME LINKED IMMUNOSPOT ASSAY; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOUS PLEURISY; UVEITIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; CHINA; DIAGNOSTIC TESTS, ROUTINE; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RHEUMATIC DISEASES; T-LYMPHOCYTES; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

MYCOBACTERIUM TUBERCULOSIS;

EID: 80054922182     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-010-0123-4     Document Type: Article

References (33)

1. van der Kooij SM, le Cessie S, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van Zeben D, Kerstens PJ et al (2009) Clinical and radiological efficacy of initial vs delayed treatment with inflix-imab plus methotrexate in patients with early rheumatoid arthritis. Ann Rheum Dis 68(7):1153-1158
2. Montecucco C (2005) In early rheumatoid arthritis the combination of methotrexate and infliximab over 2 years reduces the progression of radiological lesions more than methotrexate alone. Clin Exp Rheumatol 23(3):289-291
3. Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ (2002) TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168(9):4620-4627 (Pubitemid 34441368)
4. Jacobs M, Marino MW, Brown N, Abel B, Bekker LG, Quesni-aux VJ et al (2000) Correction of defective host response to Mycobacterium bovis BCG infection in TNF-deficient mice by bone marrow transplantation. Lab Invest 80(6):901-914 (Pubitemid 30421807)
5. Miller EA, Ernst JD (2009) Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealed. J Clin Invest 119(5):1079-1082
6. Bruns H, Meinken C, Schauenberg P, Harter G, Kern P, Modlin RL et al (2009) Anti-TNF immunotherapy reduces CD8? T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J Clin Invest 119(5):1167-1177
7. Wallis RS (2007) Reactivation of latent tuberculosis by TNF blockade: the role of interferon gamma. J Investig Dermatol Symp Proc 12(1):16-21 (Pubitemid 46763028)
8. Tuberculosis NTSGotESSf (2002) Report on fourth national epidemiological sampling survey of tuberculosis. Chin J Tuberc Respir Dis 25(1):4
9. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K et al (2004) Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 170(1):59-64 (Pubitemid 38997752)
10. Meier T, Eulenbruch HP, Wrighton-Smith P, Enders G, Regnath T (2005) Sensitivity of a new commercial enzyme-linked im-munospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis 24(8):529-536 (Pubitemid 41414002)
11. Jiang W, Shao L, Zhang Y, Zhang S, Meng C, Xu Y et al (2009) High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area. BMC Immunol 10:31
12. Chapman AL, Munkanta M, Wilkinson KA, Pathan AA, Ewer K, Ayles Het al (2002) Rapid detectionofactive and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobac-terium tuberculosis-specific T cells. AIDS 16(17):2285-2293 (Pubitemid 35449014)
13. Kaymakcalan Z, Sakorafas P, Bose S, Scesney S, Xiong L, Hanzatian DK et al (2009) Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and eta-nercept in binding to soluble and membrane tumor necrosis factor. Clin Immunol 131(2):308-316
14. Scallon B, Cai A, Solowski N, Rosenberg A, Song XY, Shealy D et al (2002) Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther 301(2):418-426 (Pubitemid 34429950)
15. Gardam MA, Keystone EC, Menzies R, Manners S, Skamene E, Long R et al (2003) Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 3(3):148-155 (Pubitemid 36278124)
16. Mohan VP, Scanga CA, Yu K, Scott HM, Tanaka KE, Tsang E et al (2001) Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun 69(3):1847-1855 (Pubitemid 32187645)
17. Carmona L, Hernandez-Garcia C, Vadillo C, Pato E, Balsa A, Gonzalez-Alvaro I et al (2003) Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol 30(7):1436-1439 (Pubitemid 36835436)
18. Bouza E, Moya JG, Munoz P (2001) Infections in systemic lupus erythematosus and rheumatoid arthritis. Infect Dis Clin North Am 15(2):335-361, vii (Pubitemid 32606903)
19. Binymin K, Cooper RG (2001) Late reactivation of spinal tuberculosis by low-dose methotrexate therapy in a patient with rheumatoid arthritis. Rheumatology (Oxford) 40(3):341-342 (Pubitemid 32266354)
20. Takasaka N, Toyota E, Shimada M, Ariga H, Teramoto S, Ak-agawa S (2010) Two cases of tuberculosis after treatment of rheumatoid arthritis with infliximab. Nihon Kokyuki Gakkai Zasshi 48(1):60-65
21. Fortaleza GT, Brito Mde F, Santos JB, Figueiredo AR, Gomes P (2009) Splenic tuberculosis during psoriasis treatment with inf-liximab. An Bras Dermatol 84(4):420-424
22. Vieira WP, Nobre CA, Filho JD, Vieira RM, Callado MR (2009) Tuberculosis meningitis during infliximab therapy. Acta Reu-matol Port 34(4):681-682
23. Winthrop KL, Siegel JN (2004) Tuberculosis cases associated with infliximab and etanercept. Clin Infect Dis 39(8):1256-1257 (Pubitemid 40169333)
24. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345(15):1098-1104
25. Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR et al (2008) American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 59(6):762-784 (Pubitemid 351847559)
26. Chadha VK, Jagannath PS, Nagaraj AV, Narayana Prasad D, Anantha N (2000) A comparative study of tuberculin reactions to 1 TU and 2 TU of PPD-RT23. Indian J TB 47:15-20
27. Hoskyns EW, Simpson H, Monk P (1994) Use of the 1 tuberculin unit (TU) Mantoux test in the assessment of tuberculous infection in children following neonatal BCG vaccination. Thorax 49(10):1006-1009 (Pubitemid 24315994)
28. Chen DY, Shen GH, Hsieh TY, Hsieh CW, Lan JL (2008) Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy. Arthritis Rheum 59(6):800-806
29. Kim HA, Yoo CD, Baek HJ, Lee EB, Ahn C, Han JS et al (1998) Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population. Clin Exp Rheumatol 16(1):9-13 (Pubitemid 28133475)
30. Targeted tuberculin testing and treatment of latent tuberculosis infection (2000) American Thoracic Society. MMWR Recomm Rep 49(RR-6):1-51
31. Teixeira EG, Kritski A, Ruffino-Netto A, Steffen R, Lapa ESJR, Belo M et al (2008) Two-step tuberculin skin test and booster phenomenon prevalence among Brazilian medical students. Int J Tuberc Lung Dis 12(12):1407-1413
32. Jeon K, Ji SH, Oh SY, Lee JB, Kim HJ, Choi CM (2008) Boosted reaction on two-step tuberculin skin test among military personnel in South Korea, a setting with an intermediate burden of tuberculosis and routine bacille Calmette-Guerin vaccination. J Korean Med Sci 23(3):402-405
33. Laffitte E, Janssens JP, Roux-Lombard P, Thielen AM, Barde C, Marazza G et al (2009) Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test. Br J Dermatol 161(4):797-800